NCT03613467View on ClinicalTrials.gov

Is Video-assisted Thoracoscopic Lobectomy a Clinical Alternative for Surgically Resectable Pathologic N2 NSCLC Patients

CompletedOBSERVATIONAL
Enrollment

2,145

Participants

Timeline

Start Date

July 4, 2018

Primary Completion Date

July 4, 2018

Study Completion Date

July 6, 2018

Conditions
Non-small Cell Lung Cancer
Interventions
PROCEDURE

VATS lobectomy

Patients who received lobectomy by video-assisted thoracoscopic surgery

PROCEDURE

Thoracotomy lobectomy

Patients who received lobectomy by thoracotomy

Trial Locations (10)

100029

China-Japan Friendship Hospital, Beijing

100853

China PLA General Hospital, Beijing

200030

Shanghai Chest Hospital, Shanghai

210009

Jiangsu cancer hospital, Nanjing

300051

Tianjin Chest Hospital, Tianjin

310003

First Hospital Affiliated to Zhejiang University, Hangzhou

430030

Tongji Hospital Affiliated to Huazhong Technology Hospital, Wuhan

450003

Henan Cancer Hospital, Zhengzhou

610041

Huaxi Hospital Affiliated to Sichuan University, Chengdu

710000

Xi'an Tangdu Hospital, Xi'an

All Listed Sponsors
collaborator

LinkDoc Technology (Beijing) Co. Ltd.

INDUSTRY

lead

Tang-Du Hospital

OTHER

NCT03613467 - Is Video-assisted Thoracoscopic Lobectomy a Clinical Alternative for Surgically Resectable Pathologic N2 NSCLC Patients | Biotech Hunter | Biotech Hunter